STAT November 20, 2025
Exact makes tests designed to detect early signs of cancer in blood and stool
Abbott said Thursday it would buy Exact Sciences, the maker of tests designed to detect cancers in early stages, in a deal worth some $21 billion, a sign of confidence in the growing cancer screening...







